Global $5+ Billion Dry Eye Syndrome Market Research Report, Size, Share, Trends and Forecast to 2024

According to the latest report by IMARC Group titled, “Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the market reached a value of US$ 3.5 Billion in 2018. Looking forward, the market is expected to reach a value of US$ 5.1 Billion by 2024, exhibiting a CAGR of around 6.5% during 2019-2024.



Request for a sample copy of this research report: https://www.imarcgroup.com/dry-eye-syndrome-market/requestsample

Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), is an ailment in which the eyes are not able to produce enough tears or when the tears evaporate too quickly. Although anyone can experience the disease, it is more common in older patients and women. Its symptoms include irritation, redness, discharge, and easily fatigued eyes. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulates the production of watery component of tears to reduce the dryness. Several factors can cause dry eye syndrome such as excessive computer use, allergies, aging, menopause and smoking.

The global dry eye syndrome treatment market is driven by the growing geriatric population, the increasing prevalence of the disease and rise in the awareness about its diagnosis and treatment. Moreover, the modern lifestyle which induces eye strain due to the heightened usage of tablets, mobile phones, and computers is further increasing eye-related problems. The other common risk factors associated with this syndrome include environmental conditions and autoimmune disorders with systemic medications. Over the last few years, there has been a rise in the availability of treatment options such as eyedrops, punctual bags and artificial tears, which is expected to add to the market growth. Moreover, focus on the development of novel technologies and the contribution of non-governmental organizations towards the diagnosis of the disease are other factors driving the growth of the market.

Market Segmentation:

Breakup by Disease Type 

Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Breakup by Drug Type
Lubricant Eye Drops
Anti-inflammatory Drugs
Autologous Serum Eye Drops

Breakup by Product 

Liquid Drops
Gel
Liquid Wipes
Eye Ointment
Others

Breakup by Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Breakup by Region

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape

The report has also examined the competitive landscape of global dry eye syndrome market. Some of the major players in the market are Novartis AG, Allergan plc., Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd., Nicox S.A., Auven Therapeutics, Akorn, Inc., Bausch + Lomb, Alimera Science and GlaxoSmithKline plc.

Key highlights of the report:

Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Competitive Structure
Profiles of Key Players

Explore full report with table of contents: https://www.imarcgroup.com/dry-eye-syndrome-market

Comments

Popular posts from this blog

Global Fertilizer Market 2022-2027 Impelled by the Introduction of Premium Quality Fertilizers

Hyper-Converged Infrastructure Market Report 2021-26: Size, Share, Trends, Scope, Demand and Opportunity

Agricultural Films Market Research Report 2022: Size, Share, Price Trends, Industry Forecast 2027